132 related articles for article (PubMed ID: 36905274)
1. Expression and significance of miR-34 with PI3K, AKT and mTOR proteins in colorectal adenocarcinoma tissues.
Li Y; Jin L; Rong W; Meng F; Wang X; Wang S; Yu X
Cell Mol Biol (Noisy-le-grand); 2022 Sep; 68(9):57-62. PubMed ID: 36905274
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA-SNHG7 acts as a target of miR-34a to increase GALNT7 level and regulate PI3K/Akt/mTOR pathway in colorectal cancer progression.
Li Y; Zeng C; Hu J; Pan Y; Shan Y; Liu B; Jia L
J Hematol Oncol; 2018 Jul; 11(1):89. PubMed ID: 29970122
[TBL] [Abstract][Full Text] [Related]
3. miR-34a and miR-125a-5p inhibit proliferation and metastasis but induce apoptosis in hepatocellular carcinoma cells via repressing the MACC1-mediated PI3K/AKT/mTOR pathway.
Zhang YM; Wu QM; Chang LY; Liu JC
Neoplasma; 2020 Sep; 67(5):1042-1053. PubMed ID: 32484698
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of miR-122-5p regulating the activation of PI3K-Akt-mTOR signaling pathway on the cell proliferation and apoptosis of osteosarcoma cells through targeting TP53 gene.
Li KW; Wang SH; Wei X; Hou YZ; Li ZH
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12655-12666. PubMed ID: 33378012
[TBL] [Abstract][Full Text] [Related]
5. microRNA-383 suppresses the PI3K-AKT-MTOR signaling pathway to inhibit development of cervical cancer via down-regulating PARP2.
Teng P; Jiao Y; Hao M; Tang X
J Cell Biochem; 2018 Jul; 119(7):5243-5252. PubMed ID: 29236322
[TBL] [Abstract][Full Text] [Related]
6. MiR-34a reverses radiation resistance on ECA-109 cells by inhibiting PI3K/AKT/mTOR signal pathway through downregulating the expression of SIRT1.
Ye Z; Xie T; Yan F; Wang L; Fang J; Wang Z; Hu F; Wang F; Fu Z
Int J Radiat Biol; 2021; 97(4):452-463. PubMed ID: 33507132
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.
Chen HX; Xu XX; Tan BZ; Zhang Z; Zhou XD
Cell Physiol Biochem; 2017; 41(3):933-946. PubMed ID: 28222438
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-99b suppresses human cervical cancer cell activity by inhibiting the PI3K/AKT/mTOR signaling pathway.
Li YJ; Wang Y; Wang YY
J Cell Physiol; 2019 Jun; 234(6):9577-9591. PubMed ID: 30480801
[TBL] [Abstract][Full Text] [Related]
9. MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway.
Luo X; Dong J; He X; Shen L; Long C; Liu F; Liu X; Lin T; He D; Wei G
Biomed Pharmacother; 2020 May; 125():109880. PubMed ID: 32004974
[TBL] [Abstract][Full Text] [Related]
10. Effects of Glut1 gene silencing on proliferation, differentiation, and apoptosis of colorectal cancer cells by targeting the TGF-β/PI3K-AKT-mTOR signaling pathway.
Wu XL; Wang LK; Yang DD; Qu M; Yang YJ; Guo F; Han L; Xue J
J Cell Biochem; 2018 Feb; 119(2):2356-2367. PubMed ID: 28884839
[TBL] [Abstract][Full Text] [Related]
11. HOTAIR/miR-326/FUT6 axis facilitates colorectal cancer progression through regulating fucosylation of CD44 via PI3K/AKT/mTOR pathway.
Pan S; Liu Y; Liu Q; Xiao Y; Liu B; Ren X; Qi X; Zhou H; Zeng C; Jia L
Biochim Biophys Acta Mol Cell Res; 2019 May; 1866(5):750-760. PubMed ID: 30742932
[TBL] [Abstract][Full Text] [Related]
12. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation.
Zheng Y; Xie L; Xu S; Yan W; Zhang H; Meng Y; Liu J; Wei X
Mol Cell Biochem; 2021 Nov; 476(11):4031-4044. PubMed ID: 34244973
[TBL] [Abstract][Full Text] [Related]
13. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
[TBL] [Abstract][Full Text] [Related]
14. microRNA-16-5p suppresses cell proliferation and angiogenesis in colorectal cancer by negatively regulating forkhead box K1 to block the PI3K/Akt/mTOR pathway.
Huang X; Xu X; Ke H; Pan X; Ai J; Xie R; Lan G; Hu Y; Wu Y
Eur J Histochem; 2022 May; 66(2):. PubMed ID: 35536149
[TBL] [Abstract][Full Text] [Related]
15. Detection of miR-34a and miR-34b/c in stool sample as potential screening biomarkers for noninvasive diagnosis of colorectal cancer.
Wu XD; Song YC; Cao PL; Zhang H; Guo Q; Yan R; Diao DM; Cheng Y; Dang CX
Med Oncol; 2014 Apr; 31(4):894. PubMed ID: 24573638
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of miR-34a Promotes Proliferation and Inhibits Apoptosis of Rat Osteoarthritic Cartilage Cells by Activating PI3K/Akt Pathway.
Tao H; Cheng L; Yang R
Clin Interv Aging; 2020; 15():373-385. PubMed ID: 32214804
[TBL] [Abstract][Full Text] [Related]
17. MiR-34a and miR-34b/c have distinct effects on the suppression of lung adenocarcinomas.
Kim JS; Kim EJ; Lee S; Tan X; Liu X; Park S; Kang K; Yoon JS; Ko YH; Kurie JM; Ahn YH
Exp Mol Med; 2019 Jan; 51(1):1-10. PubMed ID: 30700696
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
Ma T; Chen H; Wang P; Yang N; Bao J
Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
[No Abstract] [Full Text] [Related]
19. The correlation between miR -34a-3p, miR -31, PLEK2 and the occurrence, development and prognosis of colorectal cancer.
Bin H; Mei H; Hui W; Bing Z
Cell Mol Biol (Noisy-le-grand); 2022 May; 68(1):192-200. PubMed ID: 35809313
[TBL] [Abstract][Full Text] [Related]
20. miR-215-5p is an anticancer gene in multiple myeloma by targeting RUNX1 and deactivating the PI3K/AKT/mTOR pathway.
Liu S; Zhang Y; Huang C; Lin S
J Cell Biochem; 2020 Feb; 121(2):1475-1490. PubMed ID: 31498483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]